KR20150058465A - 피험체에서 간암을 진단하는 방법 및 간암을 진단하기 위한 키트 - Google Patents

피험체에서 간암을 진단하는 방법 및 간암을 진단하기 위한 키트 Download PDF

Info

Publication number
KR20150058465A
KR20150058465A KR1020157010267A KR20157010267A KR20150058465A KR 20150058465 A KR20150058465 A KR 20150058465A KR 1020157010267 A KR1020157010267 A KR 1020157010267A KR 20157010267 A KR20157010267 A KR 20157010267A KR 20150058465 A KR20150058465 A KR 20150058465A
Authority
KR
South Korea
Prior art keywords
gene
hcc
leu
subject
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020157010267A
Other languages
English (en)
Korean (ko)
Inventor
캄 만 후이
Original Assignee
싱가포르 헬스 서비시즈 피티이. 엘티디.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 싱가포르 헬스 서비시즈 피티이. 엘티디. filed Critical 싱가포르 헬스 서비시즈 피티이. 엘티디.
Publication of KR20150058465A publication Critical patent/KR20150058465A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Gastroenterology & Hepatology (AREA)
KR1020157010267A 2012-09-21 2013-09-23 피험체에서 간암을 진단하는 방법 및 간암을 진단하기 위한 키트 Withdrawn KR20150058465A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261704425P 2012-09-21 2012-09-21
US61/704,425 2012-09-21
PCT/SG2013/000414 WO2014046623A1 (en) 2012-09-21 2013-09-23 Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer

Publications (1)

Publication Number Publication Date
KR20150058465A true KR20150058465A (ko) 2015-05-28

Family

ID=50341782

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157010267A Withdrawn KR20150058465A (ko) 2012-09-21 2013-09-23 피험체에서 간암을 진단하는 방법 및 간암을 진단하기 위한 키트

Country Status (7)

Country Link
US (1) US20150232943A1 (https=)
EP (1) EP2898099A4 (https=)
JP (1) JP2015530094A (https=)
KR (1) KR20150058465A (https=)
CN (1) CN104812914B (https=)
SG (1) SG11201502089QA (https=)
WO (1) WO2014046623A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018208091A2 (ko) 2017-05-10 2018-11-15 서울대학교산학협력단 간암 고위험군의 간암 발병 모니터링 또는 진단용 바이오마커 및 그 용도

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101843173B1 (ko) * 2014-10-24 2018-03-29 씨비에스바이오사이언스 주식회사 혈관 내피 세포 성장인자 수용체 억제제에 대한 감수성 예측 방법
CN108048422A (zh) * 2017-11-30 2018-05-18 天津市湖滨盘古基因科学发展有限公司 一种gtp酶，imap家族成员7突变蛋白及其应用
CN110241198A (zh) * 2019-05-30 2019-09-17 成都吉诺迈尔生物科技有限公司 一种表征hHRD同源重组缺陷的基因组重组指纹及其鉴定方法
CN111610262A (zh) * 2020-05-19 2020-09-01 上海鹿明生物科技有限公司 一种用于肝胆疾病诊断的代谢标志物
WO2025111814A1 (zh) * 2023-11-28 2025-06-05 何牮 一种b细胞的生物标志物组及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003081201A2 (en) * 2002-03-21 2003-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
EP1682904A2 (en) * 2003-11-04 2006-07-26 Roche Diagnostics GmbH Method for distinguishing who classified aml subtypes
EP1830289A1 (en) * 2005-11-30 2007-09-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for hepatocellular carninoma classification and prognosis
WO2008138578A2 (en) * 2007-05-11 2008-11-20 Medical Prognosis Institute Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
EP2687609B1 (en) * 2008-11-10 2017-01-04 The United States of America, as represented by The Secretary, Department of Health and Human Services Method for treating solid tumor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018208091A2 (ko) 2017-05-10 2018-11-15 서울대학교산학협력단 간암 고위험군의 간암 발병 모니터링 또는 진단용 바이오마커 및 그 용도

Also Published As

Publication number Publication date
WO2014046623A1 (en) 2014-03-27
CN104812914B (zh) 2020-07-24
EP2898099A1 (en) 2015-07-29
SG11201502089QA (en) 2015-06-29
EP2898099A4 (en) 2016-05-25
JP2015530094A (ja) 2015-10-15
US20150232943A1 (en) 2015-08-20
CN104812914A (zh) 2015-07-29

Similar Documents

Publication Publication Date Title
Chalasani et al. A novel blood-based panel of methylated DNA and protein markers for detection of early-stage hepatocellular carcinoma
Jia et al. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis
Bonne et al. Salivary biomarker development using genomic, proteomic and metabolomic approaches
Qiao et al. Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection
JP3688585B2 (ja) 肺癌を診断し、モニターし、そして病期決定する新規方法
US12391992B2 (en) Kit for early screening of liver cell cancer and preparation method and use thereof
KR20150058465A (ko) 피험체에서 간암을 진단하는 방법 및 간암을 진단하기 위한 키트
JP6250600B2 (ja) 非小細胞肺癌バイオマーカーを検出する方法
US10859573B2 (en) Nourin molecular biomarkers diagnose angina patients with negative troponin
JP3538381B2 (ja) 結腸癌を診断し、モニターし、そして病期決定する新規方法
Farag et al. Studying the impact of Golgi protein 73 serving as a candidate biomarker in early diagnosis for hepatocellular carcinoma among Saudi patients
JP6876301B2 (ja) 肝細胞がん患者の再発リスク予測を補助する方法、装置、コンピュータプログラム製品及びキット
JP2008167714A (ja) 川崎病発症のリスク因子
El-Sharkawy et al. Circulating tumor cells in breast cancer: a step toward precision medicine for real-time monitoring of metastasis
Xie et al. Clinical significance of MiR-27a expression in serum exosomes in patients with heart failure
JP2002515263A (ja) 前立腺がんを診断し、モニターし、そして病期決定する新規な方法
CN113631723B (zh) 结核病标志物在结核病诊断和疗效评估中的应用
CN111304319A (zh) 一种疾病的诊断标志物及应用
WO2007053659A2 (en) Method of screening for hepatocellular carcinoma
AU2018100578A4 (en) Method for detection & diagnosis of oral cancer in a sample
CN102010903A (zh) Il-23在肝癌早期病变诊断中的应用
Xin et al. Fibrinogen Like Protein 1 as a Potential Biomarker for Hepatitis B Virus Related Hepatocellular Carcinoma
JP2025142656A (ja) アベマシクリブまたはその薬学的に許容可能な塩による肝障害発現リスクの検査方法
CN115786491A (zh) Lcn2、fcn1作为标志物在糖尿病合并结核病诊断、预后及疗效评估中的应用
CN121802031A (zh) 用于主动脉夹层检测的生物标志物及其应用

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000